Treatment of osteonecrosis of the femoral head by botulinum toxin type A injection to the psoas muscle: A case report
Anesthesia and Pain Medicine
;
: 85-90, 2017.
Artigo
em Inglês
| WPRIM
| ID: wpr-21257
ABSTRACT
Osteonecrosis of the femoral head (ONFH) can cause femoral head depression and cortical discontinuity. Treatment for ONFH remains challenging. We performed botulinum toxin type A injection to psoas major muscle in five patients with radiological femoral head collapse (Association Research Circulation Osseus classification stage III) who were non-responsive after two years of conservative treatment (tramadol 200 mg/day, mefenamic acid 1,000 mg/day). At two weeks after the procedure, their mean hip pain was decreased from 88 ± 0.4/100 mm to 22 ± 0.4/100 mm based on visual analogue scale (VAS). The pain was maintained at a minimum of 20/100 mm and a maximum of 30/100 mm in VAS for at least six weeks after the procedure. These values were mean ± SD. These patients were followed-up for 6 months. There was no exacerbation of pain from repeated (three times) botulinum toxin type A injection to the psoas major muscle.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Osteonecrose
/
Toxinas Botulínicas
/
Ácido Mefenâmico
/
Músculos Psoas
/
Classificação
/
Toxinas Botulínicas Tipo A
/
Depressão
/
Necrose da Cabeça do Fêmur
/
Cabeça
/
Quadril
Limite:
Humanos
Idioma:
Inglês
Revista:
Anesthesia and Pain Medicine
Ano de publicação:
2017
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS